Skip to main content

Advertisement

Log in

Spleen volume is a predictor of posthepatectomy liver failure and short-term mortality for hepatocellular carcinoma

  • Research
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

The study aimed at retrospectively assessing the impact of spleen volume (SpV) on the development of posthepatectomy liver failure (PHLF) in patients who underwent hepatectomy for hepatocellular carcinoma (HCC).

Methods

152 patients with primary HCC who underwent hepatectomy (sectionectomy or more) were classified into PHLF and non-PHLF groups, and then the relationship between PHLF and SpV was assessed. SpV (cm3) was obtained from preoperative CT and standardized based on the patient’s body surface area (BSA, m2).

Results

PHLF was observed in 39 (26%) of the 152 cases. SpV/BSA was significantly higher in the PHLF group, and the postoperative 1-year survival rate was significantly worse in the PHLF group than that in the non-PHLF group (p = 0.044). Multivariable analysis revealed SpV/BSA as a significant independent risk factor for PHLF. Using the cut-off value (160 cm3/m2), the 152 cases were divided into small SpV and large SpV groups. The incidence of PHLF was significantly higher in the large SpV group (p = 0.002), the liver failure-related mortality rate was also significantly higher in the large SpV group (p = 0.007), and the 1-year survival rate was significantly worse in the large SpV group (p = 0.035).

Conclusion

These results suggest SpV as a predictor of PHLF and short-term mortality in patients who underwent hepatectomy for HCC. Moreover, SpV measurement is a simple and potentially useful method for predicting PHLF in patients with HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

The data that support the findings of this study are available from the corresponding author, upon reasonable request.

References

  1. Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380:1450–1462

    Article  CAS  PubMed  Google Scholar 

  2. Vogel A, Martinelli E (2021) Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines. Annal Oncol: Official journal of the European Society for Medical Oncology 32:801–805

    Article  CAS  Google Scholar 

  3. Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Fuster J, Ayuso C, Bruix J (2022) BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 76(3):681–693

  4. Prodeau M, Drumez E, Duhamel A et al (2019) An ordinal model to predict the risk of symptomatic liver failure in patients with cirrhosis undergoing hepatectomy. J Hepatol 71:920–929

    Article  PubMed  Google Scholar 

  5. Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724

    Article  PubMed  Google Scholar 

  6. Søreide JA, Deshpande R (2021) Post hepatectomy liver failure (PHLF) – recent advances in prevention and clinical management. Euro J Surg Oncol: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 47:216–224

    Article  Google Scholar 

  7. Mizuguchi T, Kawamoto M, Meguro M et al (2014) Preoperative liver function assessments to estimate the prognosis and safety of liver resections. Surg Today 44:1–10

    Article  PubMed  Google Scholar 

  8. Garcea G, Maddern GJ (2009) Liver failure after major hepatic resection. J Hepatobiliary Pancreat Surg 16:145–155

    Article  PubMed  Google Scholar 

  9. Lafaro K, Buettner S, Maqsood H et al (2015) Defining post hepatectomy liver insufficiency: where do we stand? J Gastrointest Surg: official journal of the Society for Surgery of the Alimentary Tract 19:2079–2092

    Article  Google Scholar 

  10. Bosch J, García-Pagán JC (2000) Complications of cirrhosis. I. Portal Hypertens J Hepatol 32:141–156

    CAS  Google Scholar 

  11. Bolognesi M, Merkel C, Sacerdoti D et al (2002) Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 34:144–150

    Article  CAS  Google Scholar 

  12. Bae JS, Lee DH, Yoo J et al (2021) Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection. Eur Radiol 31:2461–2471

    Article  PubMed  Google Scholar 

  13. Peng W, Zhang XY, Li C et al (2019) Spleen stiffness and volume help to predict posthepatectomy liver failure in patients with hepatocellular carcinoma. Medicine 98:e15458

    Article  PubMed  PubMed Central  Google Scholar 

  14. Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304

    Article  CAS  PubMed  Google Scholar 

  15. Cherrick GR, Stein SW, Leevy CM et al (1960) Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Investig 39:592–600

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ohkura Y, Mizuno S, Kishiwada M et al (2014) Benefit of technetium-99m galactosyl human serum albumin scintigraphy instead of indocyanine green test in patients scheduled for hepatectomy. Hepatol Res: the official journal of the Japan Society of Hepatology 44:E118-128

    Article  CAS  Google Scholar 

  17. Ohshima S (2014) Volume analyzer SYNAPSE VINCENT for liver analysis. J Hepatobiliary Pancreat Sci 21:235–238

    Article  PubMed  Google Scholar 

  18. McCormick PA, Murphy KM (2000) Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Bailliere’s Best Pract Res Clin Gastroenterol 14:1009–1031

    Article  CAS  Google Scholar 

  19. Kohler A, Moller PW, Frey S et al (2019) Portal hyperperfusion after major liver resection and associated sinusoidal damage is a therapeutic target to protect the remnant liver. Am J Physiol Gastrointest Liver Physiol 317:G264-g274

    Article  CAS  PubMed  Google Scholar 

  20. Forbes SJ, Newsome PN (2016) Liver regeneration – mechanisms and models to clinical application. Nat Rev Gastroenterol Hepatol 13:473–485

    Article  PubMed  Google Scholar 

  21. Eipel C, Abshagen K, Vollmar B (2012) Small-for-size: experimental findings for liver surgery. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 83:238–246

    Article  CAS  PubMed  Google Scholar 

  22. Niiya T, Murakami M, Aoki T et al (1999) Immediate increase of portal pressure, reflecting sinusoidal shear stress, induced liver regeneration after partial hepatectomy. J Hepatobiliary Pancreat Surg 6:275–280

    Article  CAS  PubMed  Google Scholar 

  23. Sato Y, Koyama S, Tsukada K et al (1997) Acute portal hypertension reflecting shear stress as a trigger of liver regeneration following partial hepatectomy. Surg Today 27:518–526

    Article  CAS  PubMed  Google Scholar 

  24. Hirao H, Ito T, Kadono K et al (2021) Donor hepatic occult collagen deposition predisposes to peritransplant stress and impacts human liver transplantation. Hepatology (Baltimore, MD) 74:2759–2773

    Article  CAS  PubMed  Google Scholar 

  25. Garcea G, Ong SL, Maddern GJ (2009) Predicting liver failure following major hepatectomy. Dig Liver Dis: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 41:798–806

    Article  CAS  Google Scholar 

  26. Lam CM, Fan ST, Lo CM et al (1999) Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 86:1012–1017

    Article  CAS  PubMed  Google Scholar 

  27. Satoh K, Yamamoto Y, Nishiyama Y et al (2003) 99mTc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy. Ann Nucl Med 17:61–67

    Article  PubMed  Google Scholar 

  28. Redaelli CA, Dufour JF, Wagner M et al (2002) Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 235:77–85

    Article  PubMed  PubMed Central  Google Scholar 

  29. Lorf T, Schnitzbauer AA, Schaefers SK et al (2008) Prognostic value of the monoethylglycinexylidide (MEGX)-test prior to liver resection. Hepatogastroenterology 55:539–543

    CAS  PubMed  Google Scholar 

  30. Katsuramaki T, Mizuguchi T, Kawamoto M et al (2006) Assessment of nutritional status and prediction of postoperative liver function from serum apolioprotein A-1 levels with hepatectomy. World J Surg 30:1886–1891

    Article  PubMed  Google Scholar 

  31. Yachida S, Wakabayashi H, Kokudo Y et al (2000) Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg 24:359–364

    Article  CAS  PubMed  Google Scholar 

  32. Poon RT, Fan ST, Lo CM et al (2002) Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 236:602–611

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wong JS, Wong GL, Chan AW et al (2013) Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes. Ann Surg 257:922–928

    Article  PubMed  Google Scholar 

  34. Sunagawa Y, Yamada S, Kato Y et al (2021) Perioperative assessment of indocyanine green elimination rate accurately predicts postoperative liver failure in patients undergoing hepatectomy. J Hepatobiliary Pancreat Sci 28:86–94

    Article  PubMed  Google Scholar 

  35. Yokoyama Y, Nishio H, Ebata T et al (2010) Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg 97:1260–1268

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Ito, Tanemura, Kuramitsu, and Murase participated in the study conception and design. Ito, Tanemura, Kuramitsu, Murase, Noguchi, Fujii, and Kuriyama participated in the acquisition of data. Ito, Kuramitsu, Murase, Tenemura, and Noguchi participated in the analysis and interpretation of data. Ito, Tanemura, and Kuramitsu drafted the manuscript. Kaluba, Fujii, Noguchi, Yuge, Maeda, Hayasaki, Gyoten, Iizawa, Murata, Kuriyama, Kishiwada, and Mizuno participated in the critical revision of the manuscript.

Corresponding author

Correspondence to Takahiro Ito.

Ethics declarations

Ethics approval and consent to participate

This study was approved by Mie University Hospital Institutional Review Board (IRB#H2021-156).

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 30.5 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ito, T., Tanemura, A., Kuramitsu, T. et al. Spleen volume is a predictor of posthepatectomy liver failure and short-term mortality for hepatocellular carcinoma. Langenbecks Arch Surg 408, 297 (2023). https://doi.org/10.1007/s00423-023-03025-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00423-023-03025-w

Keywords

Navigation